These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Are there any advantages of a fixed combination in the treatment of asthma with respect to safety and tolerability?]. Virchow C Dtsch Med Wochenschr; 2009 Dec; 134 Suppl 10():S376-80. PubMed ID: 19941240 [No Abstract] [Full Text] [Related]
4. Treatment of severe asthma. Franklin W N Engl J Med; 1974 Jun; 290(26):1469-72. PubMed ID: 4151609 [No Abstract] [Full Text] [Related]
5. beta-Adrenergic bronchodilators and sudden death in asthmatics. Drug Ther Bull; 1976 Mar; 14(6):21-2. PubMed ID: 6237 [No Abstract] [Full Text] [Related]
6. The treatment of asthma. Part 2. Practical aspects of management. Paterson JW; Tarala RA Med J Aust; 1985 Nov; 143(10):453-5. PubMed ID: 2868403 [No Abstract] [Full Text] [Related]
7. The treatment of asthma. Part 1. Pharmacology of therapeutic agents. Paterson JW; Tarala RA Med J Aust; 1985 Oct; 143(9):390-4. PubMed ID: 2865668 [No Abstract] [Full Text] [Related]
11. The FDA and safe use of long-acting beta-agonists in the treatment of asthma. Chowdhury BA; Dal Pan G N Engl J Med; 2010 Apr; 362(13):1169-71. PubMed ID: 20181964 [No Abstract] [Full Text] [Related]
14. [Effect of corticosteroids on the action of sympathomimetics]. Pauwels R Bull Eur Physiopathol Respir; 1985; 21(5):53s-55s. PubMed ID: 2865993 [TBL] [Abstract][Full Text] [Related]
15. The beta-agonist controversy. Impact in COPD. Ziment I Chest; 1995 May; 107(5 Suppl):198S-205S. PubMed ID: 7743827 [No Abstract] [Full Text] [Related]
16. [Asthma therapy--too much or too little?]. von Wichert P Dtsch Med Wochenschr; 1988 May; 113(20):799-800. PubMed ID: 2897278 [No Abstract] [Full Text] [Related]
17. [Beta-2 adrenergic stimulants in the treatment of asthma: myths and realities]. Maria Y; Moneret-Vautrin DA Rev Pneumol Clin; 1989; 45(5):185-93. PubMed ID: 2576328 [TBL] [Abstract][Full Text] [Related]
18. [Update on beta-adrenergic agonists and corticosteroid aerosols]. Spector S Rev Alerg Mex; 1993; 40(6):i-iv. PubMed ID: 9296815 [No Abstract] [Full Text] [Related]
19. [Do fixed ICS/LABA-combinations have advantages in terms of patient-centered parameters?]. Buhl R Dtsch Med Wochenschr; 2009 Dec; 134 Suppl 10():S381-5. PubMed ID: 19941241 [No Abstract] [Full Text] [Related]